Back to Search
Start Over
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Tech From Acuitas Therapeutics
- Source :
- Plus Company Updates. June 7, 2023
- Publication Year :
- 2023
-
Abstract
- BERLIN: Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas' LNP technology will [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.755551639